BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7540754)

  • 1. Cathepsin-D and tumor associated antigen DF3 in salivary gland neoplasia. Differential diagnostic and prognostic applications.
    Vigneswaran N; Müller S; DeRose P; Cohen C
    Pathol Res Pract; 1994 Dec; 190(12):1174-84. PubMed ID: 7540754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immuno-histochemical evaluation of Cathepsin D in malignant salivary gland carcinomas.
    Sivaranjini Y; Angadi PV; Kumar GS
    Gulf J Oncolog; 2012 Jan; (11):38-44. PubMed ID: 22227544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of Maspin expression is a negative prognostic factor in common salivary gland tumors.
    Schwarz S; Ettl T; Kleinsasser N; Hartmann A; Reichert TE; Driemel O
    Oral Oncol; 2008 Jun; 44(6):563-70. PubMed ID: 17936671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell proliferation in salivary gland tumors.
    Skálová A; Leivo I
    Gen Diagn Pathol; 1996 Jun; 142(1):7-16. PubMed ID: 8793481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Malignant salivary gland tumors. Effect of histology and site on prognosis].
    Chilla R; Casjens R; Eysholdt U; Droese M
    HNO; 1983 Aug; 31(8):286-90. PubMed ID: 6629867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical expression of androgen receptor in salivary gland cancers.
    Sygut D; Bień S; Ziółkowska M; Sporny S
    Pol J Pathol; 2008; 59(4):205-10. PubMed ID: 19391487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human kallikrein 6 expression in salivary gland tumors.
    Darling MR; Jackson-Boeters L; Daley TD; Diamandis EP
    J Histochem Cytochem; 2006 Mar; 54(3):337-42. PubMed ID: 16286664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of p27 and Ki-67 expression in mucoepidermoid carcinoma of the intraoral minor salivary gland.
    Okabe M; Inagaki H; Murase T; Inoue M; Nagai N; Eimoto T
    Mod Pathol; 2001 Oct; 14(10):1008-14. PubMed ID: 11598171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ki-67 and p53 immunostaining assessment of proliferative activity in salivary tumors.
    Faur AC; Sas I; Motoc AG; Cornianu M; Zamfir CL; Lazăr DC; Folescu R
    Rom J Morphol Embryol; 2015; 56(4):1429-39. PubMed ID: 26743291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteopontin expression in salivary gland carcinomas.
    Bjørndal K; Larsen SR; Godballe C; Krogdahl A
    J Oral Pathol Med; 2011 Jul; 40(6):451-5. PubMed ID: 20969634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human epidermal growth factor receptor 2 (HER2) in salivary gland carcinomas.
    Clauditz TS; Reiff M; Gravert L; Gnoss A; Tsourlakis MC; Münscher A; Sauter G; Bokemeyer C; Knecht R; Wilczak W
    Pathology; 2011 Aug; 43(5):459-64. PubMed ID: 21670724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GATA3 immunohistochemical expression in salivary gland neoplasms.
    Schwartz LE; Begum S; Westra WH; Bishop JA
    Head Neck Pathol; 2013 Dec; 7(4):311-5. PubMed ID: 23604756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique expression of MUC3, MUC5AC and cytokeratins in salivary gland carcinomas.
    Lee JH; Lee JH; Kim A; Kim I; Chae YS
    Pathol Int; 2005 Jul; 55(7):386-90. PubMed ID: 15982212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunolocalization of interleukin-6 in salivary gland tumors.
    Gandour-Edwards R; Kapadia SB; Gumerlock PH; Barnes L
    Hum Pathol; 1995 May; 26(5):501-3. PubMed ID: 7538483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Mcm-2, Ki-67 and geminin in benign and malignant salivary gland tumours.
    Vargas PA; Cheng Y; Barrett AW; Craig GT; Speight PM
    J Oral Pathol Med; 2008 May; 37(5):309-18. PubMed ID: 18248354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amplification and overexpression of HER-2/neu in carcinomas of the salivary gland: correlation with poor prognosis.
    Press MF; Pike MC; Hung G; Zhou JY; Ma Y; George J; Dietz-Band J; James W; Slamon DJ; Batsakis JG
    Cancer Res; 1994 Nov; 54(21):5675-82. PubMed ID: 7522962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas.
    Edwards PC; Bhuiya T; Kelsch RD
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 May; 97(5):613-9. PubMed ID: 15153875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histologic grading and prognostic biomarkers in salivary gland carcinomas.
    Seethala RR
    Adv Anat Pathol; 2011 Jan; 18(1):29-45. PubMed ID: 21169736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [An expression of the monoclonal antibody KM-93 reactive antigen in salivary gland tumors].
    Sasaki K; Matsumura K; Tsuji T; Ogino T; Shinozaki F; Takahkshi M
    Gan No Rinsho; 1988 Feb; 34(2):138-42. PubMed ID: 2450211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of MAGE-A1 and MAGE-A3 genes in human salivary gland carcinomas.
    Liu J; Wang G; Okutomi T; Chen Z
    Chin Med J (Engl); 2003 Jun; 116(6):897-900. PubMed ID: 12877803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.